Trials / Completed
CompletedNCT05893758
Lifetech Cera™ PFO Occluder Post-Market Clinical Follow-Up
A Real-world Registry Assessing the Clinical Use of the Lifetech Cera™ PFO Occluder
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 94 (actual)
- Sponsor
- Lifetech Scientific (Shenzhen) Co., Ltd. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The objective of this post-market registry is to assess the clinical use of the Lifetech Cera™ PFO Occluder in a real-world and on-label fashion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | The Cera™ PFO Occluder | The Cera™ PFO Occluder is a percutaneous, transcatheter closure device for the non-surgical closure of Patent Foramen Ovale (PFO). |
Timeline
- Start date
- 2023-08-10
- Primary completion
- 2024-02-01
- Completion
- 2024-02-01
- First posted
- 2023-06-08
- Last updated
- 2024-08-30
Locations
5 sites across 1 country: Poland
Source: ClinicalTrials.gov record NCT05893758. Inclusion in this directory is not an endorsement.